7 research outputs found
Comparison of the mineralogy of iron ore sinters using a range of techniques
Many different approaches have been used in the past to characterise iron ore sinter mineralogy to predict sinter quality and elucidate the impacts of iron ore characteristics and process variables on the mechanisms of sintering. This paper compares the mineralogy of three sinter samples with binary basicities (mass ratio of CaO/SiO2) between 1.7 and 2.0. The measurement techniques used were optical image analysis and point counting (PC), quantitative X‐ray diffraction (QXRD) and two different scanning electron microscopy systems, namely, Quantitative Evaluation of Materials by Scanning Electron Microscopy (QEMSCAN) and TESCAN Integrated Mineral Analyser (TIMA). Each technique has its advantages and disadvantages depending on the objectives of the measurement, with the quantification of crystalline phases, textural relationships between minerals and chemical compositions of the phases covered by the combined results. Some key differences were found between QXRD and the microscopy techniques. QXRD results imply that not all of the silico‐ferrite of calcium and aluminium (SFCA types) are being identified on the basis of morphology in the microscopy results. The amorphous concentration determined by QXRD was higher than the glass content identified in the microscopy results, whereas the magnetite and total SFCA concentration was lower. The scanning electron microscopy techniques were able to provide chemical analysis of the phases; however, exact correspondence with textural types was not always possible and future work is required in this area, particularly for differentiation of SFCA and SFCA-I phases. The results from the various techniques are compared and the relationships between the measurement results are discussed
Behavior of New Zealand ironsand during iron ore sintering
A New Zealand ironsand sample was characterized by scanning electron microscopy (SEM), X-ray fluorescence spectroscopy, qualitative and quantitative X-ray diffraction, and electron probe microanalysis. The titanomagnetite-rich ironsand was added into an industrial sinter blend in the proportion of 5 wt pct, and the mixture was uniaxially pressed into cylindrical tablets and sintered in a tube furnace under flowing gas with various oxygen potentials and temperatures to develop knowledge and understanding of the behavior of titanium during sintering. An industrial sinter with the addition of 3 wt pct ironsand was also examined. Both the laboratory and industrial sinters were characterized by optical and SEM. Various morphologies of relict ironsand particles were present in the industrial sinter due to the heterogeneity of sintering conditions, which could be well simulated by the bench-scale sintering experiments. The assimilation of ironsand during sintering in a reducing atmosphere started with the diffusion of calcium into the lattice of the ironsand matrix, and a reaction zone was formed near the boundary within individual ironsand particles where a perovskite phase was generated. With increasing sintering temperature, in a reducing atmosphere, ironsand particles underwent further assimilation and most of the titanium moved from the ironsand particles into a glass phase. In comparison, more titanium remained in the original ironsand particles when sintered in air. Ironsand particles are more resistant to assimilation in an oxidizing atmosphere
Effect of addition of mill scale on sintering of iron ores
Iron-rich (65 to 70 pct total Fe) mill scale generated during processing by steel mills can be recycled by using it as a ferrous raw material in the sintering process. The effect of mill scale addition on the phase formation of sintered specimens from an industrial sinter blend containing 0 to 15 wt pct mill scale was examined, and the mineral phases formed during sintering under various conditions (T = 1523 K to 1598 K [1250 °C to 1325 °C] and gas compositions of pO2 = 0.5, 5 and 21 kPa) were quantitatively measured. For samples sintered in air (pO2 = 21 kPa), there was negligible effect of mill scale addition on the phases formed. The oxidation of the mill scale was complete, and phases such as Silico-Ferrite of Calcium and Aluminum (SFCA), SFCA-I, and hematite dominated. Under lower oxygen partial pressures (pO2 = 0.5 or 5 kPa), and throughout the temperature range examined, the mill scale was converted to magnetite, with the extent of reaction controlled by the hematite-magnetite conversion kinetics. When sintered in the gas mixture with pO2 = 5 kPa, an increase in the mill scale content from 0 to 15 wt pct resulted in a decrease of hematite and total SFCA phases and a corresponding increase in the amount of magnetite which formed. The oxidation of wustite in mill scale to magnetite decreased the local partial pressure of O2 and increased sintering temperature, which promoted the decomposition of hematite
An investigation of goethite-seeded Al(OH)3 precipitation using in situ X-ray diffraction and Rietveld-based quantitative phase analysis
An in situ X-ray diffraction investigation of goethite-seeded Al(OH)3 precipitation from synthetic Bayer liquor at 343 K has been performed. The presence of iron oxides and oxyhydroxides in the Bayer process has implications for alumina reversion, which causes significant process losses through unwanted gibbsite precipitation, and is also relevant for the nucleation and growth of scale on mild steel process equipment. The gibbsite, bayerite and nordstrandite polymorphs of Al(OH)3 precipitated from the liquor; gibbsite appeared to precipitate first, with subsequent formation of bayerite and nordstrandite. A Rietveld-based approach to quantitative phase analysis was implemented for the determination of absolute phase abundances as a function of time, from which kinetic information for the formation of the Al(OH)3 phases was determined
Effects of sintering materials and gas conditions on formation of silico-ferrites of calcium and aluminium during iron ore sintering
Silico-ferrites of calcium and aluminium (SFCA) are desirable phases in a high quality iron ore sinter product. The effects of sintering temperature, CaO/SiO2 ratio, sintering gas atmosphere and cooling procedure on the phase composition of sintered specimens from an industrial sinter blend were examined with focus on the formation of SFCA phases. The proportions of mineral phases in specimens sintered at 1 250-1 325°C were quantitatively examined using image analysis. SFCA can be formed at low temperatures by solid state reactions, the formation of which was enhanced by increasing temperature. Further increasing sintering temperature promoted the reduction of Fe3+ in the SFCA crystal structure to Fe2+ and consequent decomposition of SFCA. At high temperatures, SFCA was produced during cooling via crystallisation from a silicate melt. Maintaining a high oxygen partial pressure favours the formation of SFCA, either via solid state reactions or from a melt. This is attributed to hematite being available as a reactant for SFCA formation. Similarly, increasing CaO/SiO2 ratio provides more CaO as a reactant and promotes SFCA formation
Whole-genome sequencing reveals host factors underlying critical COVID-19
Altres ajuts: Department of Health and Social Care (DHSC); Illumina; LifeArc; Medical Research Council (MRC); UKRI; Sepsis Research (the Fiona Elizabeth Agnew Trust); the Intensive Care Society, Wellcome Trust Senior Research Fellowship (223164/Z/21/Z); BBSRC Institute Program Support Grant to the Roslin Institute (BBS/E/D/20002172, BBS/E/D/10002070, BBS/E/D/30002275); UKRI grants (MC_PC_20004, MC_PC_19025, MC_PC_1905, MRNO2995X/1); UK Research and Innovation (MC_PC_20029); the Wellcome PhD training fellowship for clinicians (204979/Z/16/Z); the Edinburgh Clinical Academic Track (ECAT) programme; the National Institute for Health Research, the Wellcome Trust; the MRC; Cancer Research UK; the DHSC; NHS England; the Smilow family; the National Center for Advancing Translational Sciences of the National Institutes of Health (CTSA award number UL1TR001878); the Perelman School of Medicine at the University of Pennsylvania; National Institute on Aging (NIA U01AG009740); the National Institute on Aging (RC2 AG036495, RC4 AG039029); the Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS.Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care or hospitalization after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genes-including reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)-in critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease